2024

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

OS Therapies Announces Pricing of $6 Million Private Placement

MAXONA Pharmaceuticals Closes on $6,960,500 Series B Convertible Preferred Stock Offering

Marker Therapeutics Announces $16.1 Million Private Placement

Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II

Medicus Pharma Ltd. Announces Pricing of US$4.0M Initial Public Offering in the United States

Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million

Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules